Rebecca Markovich's most recent trade in Talis Biomedical Corp was a trade of 13,071 Stock option (right to buy) done . Disclosure was reported to the exchange on July 17, 2023.
Stock | Client Name | Client Category | Action | Reported to Exchange | Quantity | Post Transaction Holding | Traded % | Avg. Price | Value | Security Type |
---|---|---|---|---|---|---|---|---|---|---|
Talis Biomedical Corp | Rebecca Markovich | Interim CFO | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 17 Jul 2023 | 13,071 | 13,071 | - | - | Stock option (right to buy) |